Effect of selective and non-selective muscarinic blockade on baclofen inhibition of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats

Carcinogenesis

Volumn 17, Issue 2, 1996, Pages 293-296

  Tatsuta, Masaharu ^a   Iishi, Hiroyasu ^a   Baba, Miyako ^a   Yano, Hiroyuki ^a   Uehara, Hiroyuki ^a   Nakaizumi, Akihiko ^a  

^a CENTER FOR ADULT DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; BACLOFEN; METHYLNITRONITROSOGUANIDINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PIRENZEPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFECT; INCIDENCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH ANTRUM; STOMACH CANCER; STOMACH MUCOSA; SUBCUTANEOUS DRUG ADMINISTRATION;

ADENOCARCINOMA; ANIMALS; ATROPINE; BACLOFEN; BROMODEOXYURIDINE; CARCINOGENS; GABA AGONISTS; MALE; METHYLNITRONITROSOGUANIDINE; MUSCARINIC ANTAGONISTS; NEOPLASMS, EXPERIMENTAL; PIRENZEPINE; RATS; RATS, WISTAR; STOMACH NEOPLASMS;

EID: 0029971395     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.2.293     Document Type: Article

References (24)

1. Tatsuta,M., Iishi,H., Baba,M., Nakaizumi,A., Ichii,M. and Taniguchi,H. (1990) Inhibition by gamma-amino-n-butyric acid and baclofen of gastric carcinogenesis induced by .N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Cancer Res., 50, 4931-4934.
2. Hara,N., Hara,Y., Natsume,Y. and Goto,T. (1990) Direct evidence indicating that a GABA-mimetic stimulates acid secretion through central mechanisms. Jpn. J. Pharmacol., 53, 271-274.
3. Thirlby,R.C., Stevens,M.H., Blair,AJ., Petty,F., Crawford,I.L., Taylor,I.L., Walsh,J.H. and Feldman,M. (1988) Effect of GABA on basal and vagally mediated gastric acid secretion and hormone release in dog. Am. J. Physiol., 254, G723-G731.
4. Pugh,S., Lewin,M.R., Williams,S., Barton,T.P. and Clark,C.G. (1985) Baclofen (PCP-GABA) as a stimulant of gastric acid secretion in man. IRCS Med. Sci., 13, 1082-1083.
5. Goto,Y. Hollinshead,J.H. and Debas,H.T. (1984) A new intraoperative test for completeness of vagotomy: the PCPGABA (beta-parachlorphenyl-gamma-aminobutyric acid) test. Am. J. Surg., 147, 159-163.
6. Andrews,P.L.R. and Wood,K.L. (1986) Systemic baclofen stimulates gastric motility and secretion via central action in the rat. Br. J. Pharmacol., 89, 461-467.
7. Wood,K.L., Addae,J.I., Andrew,P.L.R. and Stone,T.W. (1987) Injection of baclofen into the ventromedial hypothalamus stimulates rat gastric acid secretion. Neuropharmacologv. 26, 1191-1194.
8. Hashimoto,Y., Nagahata,Y., Urakawa,T. and Saitoh,Y. (1992) Inhibitory effect of peptide YY on gastric acid output in rats. Jpn. J. Gastroenterol., 89, 1-8.
9. Yokotani,K., Del Valle,J., Park,J. and Yamada,T. (1995) Muscarinic M3 receptor-mediated release of gastrin from canine antral G cells in primary culture. Digestion. 56, 31-34.
10. Garrigues,V., Ponce,J., Cano,C., Sopena,R., Hoyos,M., Del Val,A. and Berenguer,J. (1992) Effect of selective and nonselective muscarinic blockade on cholecystokinin-induced gallbladder emptying in man. Dig. Dis. Sci., 37, 101-104.
11. Tatsuta,M., Iishi,H., Yamamura,H., Baba,M., Yamamoto,R. and Taniguchi,H. (1988) Effect of cimetidine on inhibition by tetragastrin of carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Cancer Res., 48, 1591-1595.
12. Gratzner,H.G. (1982) Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science, 218, 474-175.
13. Morstyn,G., Hsu,S.M., Kinsella,T., Gratzner,H., Russo,A. and Mitchell,J.B. (1983) Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody. J. Clin. Invest., 72, 1844-1850.
14. Eastwood,G.L. and Quimby,G. (1983) Effect of chronic cimetidine ingestion on fundic and antral epithelial proliferation in the rat. Dig. Dis. Sci., 28, 61-64.
15. Miller,R.G.Jr (1966) Simultaneous Statistical Inference. McGraw-Hill, New York, NY.
16. Snedecor,C.W. and Cochran.W.C. (1967) Statistical Methods. Iowa State University Press, Ames, IA.
17. Gurkalo,V.K. and Zabezhinski,M.A. (1982) On participation of the autonomic nervous system in the mechanisms of chemical carcinogenesis. Neoplasma, 29, 301-307.
18. Gurkalo,V.K. and Volfson,N.I.(1982) Nicotine influence upon the development of experimental stomach tumors. Arch. Geschwulstforsch., 4, 259-265.
19. Gurkalo,V.K. and Volfson,N.J. (1980) Morphopharmacological analysis of the carcinogenic properties of N-methyl-N′-nitro-N-nitrosoguanidine. Exp. Pathol., 18, 353-359.
20. Tatsuta,M., Iishi,H., Yamamura,H., Baba,M. and Taniguchi,H. (1989) Inhibition by neostigmine and isoproterenol and promotion by atropine of experimental carcinogenesis in rat stomach by N-methyl-N′-nitro-N-nitrosoguanidine. Int. J. Cancer, 44, 188-189.
21. 2. biochemical and functional characterization. Life Sci., 31, 2991-2998.
22. 2 receptor antagonist. Life Sci., 38, 1663-1672.
23. Melchiorre,C. (1988) Polymethylene tetramines: a new generation of selective muscarinic antagonists. Trends Pharmacol. Sci., 9, 216-220.
24. 2 muscarinic receptors. Br. J. Pharmacol., 85, 427-435.